Madrigal Pharmaceuticals <MDGL.O>: Barclays cuts target price to $962 from $964
MDGL•Related News
AmBase Q2 FY26 net loss narrows to $736,000 from year-ago period
ABCP•
Nasdaq Trade Halt <OFAL.O> Volatility Trading Pause at 11:56 AM
OFAL•
Nasdaq trade halt continues <UCFI.O> reason not available at 12:01 PM
UCFI•
GAMCO Natural Resources, Gold & Income Trust declares $0.06 monthly distribution for October-December 2026
GNT•
Solitron Devices CEO Tim Eriksen reports disposal of 563 common shares worth $19,602.66
SODI•